FDA Peptide Reclassification 2026: Category 2 Removals Explained
An updated explanation of the FDA’s April 2026 peptide reclassification, Category 2 removals, upcoming PCAC review, and what the changes may mean for compounding pharmacies and patients.
May 15, 20265 min read
Read Article ›